克隆性血液形成与多发性骨髓瘤无关,并且与特定的微环境变化有关
Marta Lionetti1, Margherita Scopetti2, Antonio Matera2
1University of Milan, MILAN, Italy.
Blood
|March 20, 2025
概括
不确定潜力的克隆性血液形成 (CHIP) 经常与多发性骨髓瘤 (MM) 共同存在,破坏瘤微环境 (TME) 并促进炎症和免疫逃避. 这种关联表明CHIP可能会恶化MM的进展和治疗耐药性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 多发性骨髓瘤 (MM) 的进展受到瘤微环境 (TME) 的影响.
- 不确定的潜力 (CHIP) 的克隆性血液形成与炎症的微环境有关.
- 在MM TME中CHIP的作用仍然不清楚.
研究的目的:
- 在多发性骨髓瘤患者中调查CHIP和TME之间的关联.
- 为了鉴定CHIPMM患者的TME变化的特征.
主要方法:
- 对106名MM患者进行CHIP共存的分析.
- 16名MM患者的单细胞RNA测序,有或没有CHIP.
- 推断的细胞与细胞相互作用分析.
主要成果:
- 在诊断时,CHIP经常与MM共存,与晚期R-ISS阶段和更高的年龄有关.
- 存在CHIP会改变MM TME,减少原始T细胞和抗原呈现细胞.
- CHIP诱导了一种促炎性TME,在CD8细胞上增加了免疫衰竭标志物.
结论:
- 在诊断时,CHIP显著扰乱了MM TME,反映了晚期疾病中出现的变化.
- CHIP可能会促进MM的进展,免疫逃避和治疗耐药性.
- 需要进一步的研究来探索CHIP在修改MM TME中的作用.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Cells of the Adaptive Immune Response
738
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
738
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


